Navigation Links
HIV Drugs May Help Protect Young Patients' Hearts: Study
Date:4/22/2013

MONDAY, April 22 (HealthDay News) -- Long-term use of powerful drug cocktails known as highly active antiretroviral therapy (HAART) may help protect the hearts of children and teens infected with HIV, a new study reports.

HAART is a form of antiretroviral therapy that is widely used to treat people with HIV, the virus that causes AIDS. Prior to the introduction of antiretroviral therapies, youngsters infected with HIV were at increased risk for heart failure, noted a team led by Dr. Steven Lipshultz of the University of Miami Miller School of Medicine.

Since the advent of powerful HIV-suppressing medications, "the effects of HIV and [antiretroviral therapy] on the cardiovascular system of HIV-infected children are not completely understood," the researchers wrote in the April 22 online issue of JAMA Pediatrics. They pointed out that such children are exposed to these drugs for many years, often beginning while they are still in the womb, but the effects on their cardiovascular systems "are unknown."

The new study sought to clear that up. It included nearly 600 HIV-infected and uninfected patients from 14 pediatric HIV clinics across the United States.

According to the team, heart function was better among HIV-infected children receiving HAART than those who were infected with HIV and did not receive HAART, and children who were exposed to HIV but not infected.

"Our results indicate that the current use of combination [antiretroviral therapy], usually HAART, appears to be cardioprotective in HIV-infected children and adolescents," the study authors reported. "This finding is even more relevant in the developing world where the prevalence of HIV disease in children is much higher."

The researchers added that further study comparing different drug regimens might be beneficial "in optimizing HIV outcomes and protecting long-term cardiac health" of children with HIV.

More information

The New Mexico AIDS Education and Training Center has more about children and HIV.

-- Robert Preidt

SOURCE: JAMA Pediatrics, news release, April 22, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Is your migraine preventive treatment balanced between drugs benefits and harms?
2. Drugs Can Cut Breast Cancer Risk for Some, Task Force Finds
3. Lucintel Report Outlines $100 Billion Market for Global Oncology Drugs Industry in 2018
4. No evidence drugs, vitamins, supplements help prevent cognitive decline in healthy older adults
5. Interactions between drugs can also be measured at lowest doses
6. GUMBOS technology promises new drugs, electronic devices
7. TGen-Scottsdale Healthcare clinical trial finds new class of cancer drugs safe and effective
8. FDA and Legislators Introduce Bill Aimed at Reclassifying and Restricting Hydrocodone Drugs
9. Cisplatin-resistant cancer cells sensitive to experimental anticancer drugs, PARP inhibitors
10. Corporate Whistle Blower Center Now Urges All Physicians or Medical Device-Drug Maker Insiders to Cash In If They Have Proof A Company Knowingly Sold Bad Drugs Or Devices
11. Bel Marra Health Reports on a New Harvard Study: Abuse of Prescription Drugs and Alcohol on the Steady Upswing
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
HIV Drugs May Help Protect Young Patients' Hearts: Study
(Date:6/26/2016)... Charlotte, NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind ... able to be personalized through a fitness app. The fitness app plans to fix the ... solutions currently only offer a one size fits all type program , They ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... ... 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to a ... new, often overlooked aspect of head lice: the parasite’s ability to live away from a ... occurrence, but a necessary one in the event that lice have simply gotten out of ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... , , , WHEN: ... , , , , LOCATION: , , , Online, with ... , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global Vice ... Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... industry is witnessing an exceptional era. Several new demand spaces, such ...
(Date:6/23/2016)... -- The vast majority of dialysis patients currently receive ... usually 3 times a week, with treatment times averaging ... equipment preparation and wait time.  This regimen can be ... who are elderly and frail.  Many elderly dialysis patients ... for some duration of time. Residents in ...
Breaking Medicine Technology: